Related references
Note: Only part of the references are listed.Functional Screening of Alzheimer Pathology Genome-wide Association Signals in Drosophila
Joshua M. Shulman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody
Scott A. Yuzwa et al.
AMINO ACIDS (2011)
Targeting Post-translational Modifications on Tau as a Therapeutic Strategy for Alzheimer's Disease
Jacob Newman Marcus et al.
JOURNAL OF NEUROGENETICS (2011)
Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation
Caroline Smet-Nocca et al.
MOLECULAR BIOSYSTEMS (2011)
Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns
Elizabeth K. Culyba et al.
SCIENCE (2011)
Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease
Tony Lefebvre et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Elevation of Global O-GlcNAc in Rodents Using a Selective O-GlcNAcase Inhibitor Does Not Cause Insulin Resistance or Perturb Glucohomeostasis
Matthew S. Macauley et al.
CHEMISTRY & BIOLOGY (2010)
Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry
Zihao Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Fei Liu et al.
BRAIN (2009)
Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice
Yumiko Uno et al.
BRAIN RESEARCH (2009)
Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease
Ying Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability
Sarah R. Hanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural insights into mechanism and specificity of O-GlcNAc transferase
Andrew J. Clarke et al.
EMBO JOURNAL (2008)
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2008)
TAK1-binding protein 1 is a pseudophosphatase
Sarah H. Conner et al.
BIOCHEMICAL JOURNAL (2006)
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies
Matthew R. Reynolds et al.
JOURNAL OF NEUROSCIENCE (2006)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting
X Li et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Post-translational modifications of tau protein in Alzheimer's disease
CX Gong et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Glucose metabolism and Alzheimer's disease
D Schubert
AGEING RESEARCH REVIEWS (2005)
Triggers of full-length tau aggregation: A role for partially folded interrnediates
CN Chirita et al.
BIOCHEMISTRY (2005)
Effects of different anti-tau antibodies on tau fibrillogenesis: RTA-1 and RTA-2 counteract tau aggregation
T Taniguchi et al.
FEBS LETTERS (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins -: a role in nuclear localization
T Lefebvre et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility
N Sahara et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dynamic O-glycosylation of nuclear and cytosolic proteins -: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain
Y Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells
V Vogelsberg-Ragaglia et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
